Home › Obesity › Michigan › Grand Rapids
Obesity clinical trials in Grand Rapids, MI
4 studies for Obesity are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
RecruitingPhase 3
- Helen Devos Childrens' Hospital - PIN, Grand Rapids
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- Helen Devos Childrens' Hospital - PIN, Grand Rapids
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Healthy Heart Cardiology, Grand Rapids
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Corewell Health, Grand Rapids
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL40 studies
- New York City, NY39 studies
- San Antonio, TX39 studies
- Washington, DC34 studies
- Dallas, TX33 studies
- Orlando, FL33 studies
- Miami, FL28 studies
- Boston, MA26 studies
- Atlanta, GA26 studies
- Los Angeles, CA25 studies
- St. Louis, MO25 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer46 studies
- Colorectal Cancer40 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Ovarian Cancer25 studies
- Metastatic Cancer21 studies
- Prostate Cancer21 studies
- Stomach Cancer20 studies
- Pancreatic Cancer19 studies
- Endometrial Cancer18 studies
- Head and Neck Squamous Cell Carcinoma17 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.